博士

主治医师

女性生殖系统肿瘤基础临床研究

1.Wang Y#, Liu T#, Li H*. Enhancement of triptolide-loaded micelles on tumorigenicity inhibition of human ovarian cancer.J Biomater Sci Polym Ed. 2016 ,27(7):545-56. 2.Wang Y#, Yu YN#, Song S#, Li TJ, Xiang JY, Zhang H, Lu MD, Ji F*, Hu LQ*. JAB1 and phospho-Ser10 p27 expression profile determine human hepatocellular carcinoma prognosis. J Cancer Res Clin Oncol, 2014,140(6): 969-978. 3.Wang Y#, Wang Y#, Xiang J#, Ji F, Deng Y, Tang C, Yang S, Xi Q, Liu R*, Di W*. Knockdown of CRM1 inhibits the nuclear export of p27(Kip1) phosphorylated at serine 10 and plays a role in the pathogenesis of epithelial ovarian cancer. Cancer Lett, 2014 ,343(1):6-13. 4. Ji F#, Wang Y#, Qiu L, Li S, Zhu J, Liang Z, Wan Y, Di W*. Hypoxia inducible factor 1α-mediated LOX expression correlates with migration and invasion in epithelial ovariancancer. Int J Oncol, 2013,42(5):1578-1588. 5.Qiu LX#*, Wang Y#, Xia ZG, Xi B, Mao C, Wang JL, Wang BY, Lv FF, Wu XH, Hu LQ*. miR-196a2 C allele is a low-penetrant risk factor for cancer development. Cytokine, 2011, 56(3):589-92. 6.Wang Y#, Wang Y#, Cheng C, Ji Y, Zhao Y, Zou L, Shen A*. Expression of Jun activation domain- binding protein 1 and Ser10 phosphorylated p27 protein in human epithelial ovarian carcinoma. J Cancer Res Clin Oncol, 2009, 135(7): 951-959.

2011/9–2014/7，上海交通大学，医学院附属仁济医院，妇产科，博士 2013/4-2014/4，美国西奈山医学院，肿瘤学系，访问学者 2005/9–2008/7，南通大学，医学院，病理学，硕士 2000/9–2005/7，南通大学，医学院，临床医学，学士